These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 498718)

  • 21. Inheritance of acetylator phenotype in mice.
    Tannen RH; Weber WW
    J Pharmacol Exp Ther; 1980 Jun; 213(3):480-4. PubMed ID: 6970808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age and dosage dependency in the plasma disposition and the renal clearance of sulfamethazine and its N4-acetyl and hydroxy metabolites in calves and cows.
    Nouws JF; Vree TB; Baakman M; Driessens F; Breukink HJ; Mevius D
    Am J Vet Res; 1986 Mar; 47(3):642-9. PubMed ID: 3963566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
    Andres HH; Weber WW
    Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture.
    Gunawardhana L; Barr J; Weir AJ; Brendel K; Sipes IG
    Drug Metab Dispos; 1991; 19(3):648-54. PubMed ID: 1680632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simplified micromethod for the determination of the acetylator phenotype.
    Hoo JJ; Hussein L; Goedde HW
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):329-31. PubMed ID: 894203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible optimization of sulphadimidine dosage for acetylator phenotyping.
    Hombhanje F
    Jpn J Pharmacol; 1991 Aug; 56(4):531-4. PubMed ID: 1744992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic acetylator polymorphism in breast cancer patients.
    Ladero JM; Fernández MJ; Palmeiro R; Muñoz JJ; Jara C; Lázaro C; Pérez-Manga G
    Oncology; 1987; 44(6):341-4. PubMed ID: 3684174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of hypercapnia and (or) hypoxemia and metabolic acidosis on sulfamethazine kinetics in the conscious rabbit.
    Du Souich P; Courteau H
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1170-7. PubMed ID: 6498628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?
    Peters JH; Gordon GR; Lin E; Green CE; Tyson CA
    Anticancer Res; 1990; 10(1):225-9. PubMed ID: 2334132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the sulphadimidine acetylator phenotyping test in patients with reduced renal function.
    Hall S
    Acta Med Scand; 1981; 209(6):505-7. PubMed ID: 7257867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
    Martell KJ; Levy GN; Weber WW
    Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between N-acetyltransferase activities in uroepithelia and in vivo acetylator phenotype.
    Pink JC; Messing EM; Reznikoff CA; Bryan GT; Swaminathan S
    Drug Metab Dispos; 1992; 20(4):559-65. PubMed ID: 1356735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphamethoxazole acetylation in fast and slow acetylators.
    Bozkurt A; Basci NE; Isimer A; Tuncer M; Erdal R; Kayaalp SO
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):164-6. PubMed ID: 2338369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.
    Reeves PT; Minchin RF; Ilett KF
    J Pharmacol Exp Ther; 1989 Jan; 248(1):348-52. PubMed ID: 2913280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of monomorphic and polymorphic N-acetyltransferases in human colon.
    Ilett KF; Ingram DM; Carpenter DS; Teitel CH; Lang NP; Kadlubar FF; Minchin RF
    Biochem Pharmacol; 1994 Mar; 47(5):914-7. PubMed ID: 8135868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW; Omichinski JG; Brewer JA; Weber WW
    J Pharmacol Exp Ther; 1982 Jan; 220(1):8-15. PubMed ID: 7053425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylation phenotyping with sulfamethazine in an Iranian population.
    Sardaş S; Lahijany B; Cok I; Karakaya AE
    Pharmacogenetics; 1993 Jun; 3(3):131-4. PubMed ID: 8334437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, metabolism, and renal excretion of sulfadimidine and its N4-acetyl and hydroxy metabolites in humans.
    Vree TB; Hekster YA; Nouws JF; Baakman M
    Ther Drug Monit; 1986; 8(4):434-9. PubMed ID: 3824429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.